The VITESSE study is currently enrolling participants!
If your child is between 4 and 7 years of age, and has been diagnosed with a peanut allergy but has never received treatment, please click on the button below for more information about the trial.
This study is a double-blind, placebo-controlled, randomized phase III trial to study the efficacy and safety of peanut skin patch immunotherapy with Viaskin® Peanut in peanut-allergic children 4-7 years of age.
